Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

LXEOLXEO
Showing 8 of 11 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in LEXEO THERAPEUTICS INC

NORTHERN TRUST CORP holds 867,391 shares of LXEO (LEXEO THERAPEUTICS INC), worth $4M as of 2026-Q2. The position was increased (+75.7% shares). LXEO represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$4M

Current Shares

867,391

Total Value Change

+$2.2M

Total Shares Change

+667,292

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
867,391
+75.7%
$4M0.0%$4.66
40
2026-Q1
Increased
493,666
+8.0%
$2.8M0.0%$7.07
28
2025-Q4
Increased
457,052
+93.3%
$4.5M0.0%$9.74
43
2025-Q3
Increased
236,453
+17.8%
$1.6M0.0%$6.66
30
2025-Q2
Decreased
200,786
-2.6%
$807,1590.0%$4.12
0
2025-Q1
Decreased
206,093
-3.8%
$715,1430.0%$4.10
0
2024-Q4
Increased
214,284
+7.1%
$1.4M0.0%$6.54
27
2024-Q3
Increased
200,099
+110.8%
$1.8M0.0%$9.11
42

Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used